BLAU (BLAU3) Main Indicators
Basic Data - BLAU3
| Company | BLAU |
| Corporate Name | BLAU FARMACÊUTICA S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | A Companhia dedica-se à fabricação. comercialização. pesquisa e desenvolvimento de medicamentos de alta complexidade. |
| Share | BLAU3 |
| Quote Date | 11/22/2024 |
| Share Type | ON |
| Last Closing | R$ 14.70 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 1.96 M |
| Last Statement | ITR - 09/30/2024 |
| Sector | Saúde |
| Subsector | Comércio e Distribuição |
| Segment | Medicamentos e Outros Produtos |
| Participation Indexes | IBRA, ICON, IGC, IGCT, IGNM, ITAG, SMLL |
| Updated 11/23/2024 | |
Relative Prices - BLAU3
| Price/Earnings | 14.10 |
| Price/SBV | 1.26 |
| Price/Net Sales | 1.56 |
| Price/CFO | 7.93 |
| Price/FCF | 12.31 |
| Price/Total Assets | 0.81 |
| Price/EBIT | 9.92 |
| Price/Working Capital | 2.33 |
| Price/NCAV | -185.89 |
| EV/EBIT | 11.91 |
| EV/EBITDA | 10.03 |
| EV/Net Sales | 1.88 |
| EV/CFO | 9.52 |
| EV/FCF | 14.78 |
| EV/Total Assets | 0.98 |
| Company Market Cap | R$ 2.64 B |
| Enterprise Value | R$ 3.17 B |
| Current Financial Statement Date | 09/30/2024 |
| Current Share Price | R$ 14.70 |
| Share Price Date | 11/22/2024 |
| Dividend Yield | 2.48% |
| Updated 11/23/2024 | |
Income Statement - BLAU3
| Net Revenue | R$ 1.69 B |
| Gross Result | R$ 596.47 M |
| EBIT | R$ 265.92 M |
| Depreciation and Amortization | - R$ 49.87 M |
| EBITDA | R$ 315.79 M |
| Net Profit | R$ 187.05 M |
| Net Profit/Share | R$ 1.04 |
| Updated 11/06/2024 | |
| Net Revenue | R$ 473.57 M |
| Gross Result | R$ 187.13 M |
| EBIT | R$ 105.46 M |
| Depreciation and Amortization | - R$ 12.51 M |
| EBITDA | R$ 117.97 M |
| Net Profit | R$ 70.55 M |
| Profit/Share | R$ 0.39 |
| Updated 11/06/2024 | |
Price and Volume Behavior - BLAU3
| Lowest Price 52 weeks | R$ 9.21 |
| Highest Price 52 weeks | R$ 17.00 |
| Variation 2024 | -2.01% |
| Variation 1 year | -6.02% |
| Variation 2 years(total) | -44.30% |
| Variation 2 years(yearly) | -25.34% |
| Variation 3 years(total) | -58.50% |
| Variation 3 years(yearly) | -25.39% |
| Variation 4 years(total) | - |
| Variation 4 years(yearly) | - |
| Variation 5 years(total) | - |
| Variation 5 years(yearly) | - |
| Average Daily Volume (3 months) | R$ 4.79 M |
| Updated 11/23/2024 | |
Returns and Margins - BLAU3
| Return on Initial Tangible Capital | 7.37% |
| Return on Initial Invested Capital | 6.89% |
| Pre-Tax Return on Initial Tangible Capital | 11.16% |
| Pre-Tax Return on Initial Invested Capital | 10.44% |
| Return on Initial Shareholder´s Equity | 9.47% |
| Return on Initial Asset | 6.08% |
| Gross Margin | 35.38% |
| Net Margin | 11.10% |
| EBIT Margin | 15.77% |
| EBITDA Margin | 18.73% |
| Initial Asset Turnover | 0.55 |
| Financial Leverage | 1.55 |
| Liabilities/Net Worth | 0.55 |
| Net Debt/EBITDA | 1.67 |
| Updated 11/06/2024 | |
Balance Sheet - BLAU3
| Cash and Cash Equivalents | R$ 20.71 M |
| Total Assets | R$ 3.24 B |
| Short-Term Debt | R$ 66.00 M |
| Long-Term Debt | R$ 483.52 M |
| Gross Debt | R$ 549.51 M |
| Net Debt | R$ 528.81 M |
| Shareholder´s Equity | R$ 2.10 B |
| Share Book Value | R$ 11.69 |
| Common Shares | 179,393,939 |
| Preferred Shares | 0 |
| Total | 179,393,939 |
| Common Shares in Treasury | 1,713,200 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 1,713,200 |
| Common Shares (Except Treasury) | 177,680,739 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 177,680,739 |
| Updated 11/06/2024 | |
Cash Flow - BLAU3
| Operating Cash Flow | R$ 332.65 M |
| Cash Flow from Investments | - R$ 140.62 M |
| Financing Cash Flow | - R$ 201.67 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 9.64 M |
| Updated 11/06/2024 | |
| Operating Cash Flow | R$ 156.16 M |
| Cash Flow from Investments | - R$ 111.00 M |
| Financing Cash Flow | - R$ 44.87 M |
| Increase (Reduction) in Cash and Equivalents | R$ 285.00 thousand |
| Updated 11/06/2024 | |
Experimental - BLAU3
| CAPEX 3 months | - R$ 34.58 M |
| Free Cash Flow 3 months | R$ 121.58 M |
| CAPEX 12 months | - R$ 118.48 M |
| Free Cash Flow 12 months | R$ 214.17 M |
| Updated 11/06/2024 | |